Cargando…

Development of second primary cancer in Korean breast cancer survivors

PURPOSE: Breast cancer survivors have slightly increased the risk of second primary cancers. Breast, colon, uterine, and ovarian cancers are common secondary cancers in breast cancer survivors. In this study, we assessed the development of second primary cancers of breast cancer survivors in Korea....

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Hong Kyu, Park, Suyeon, Kim, Nam Won, Lee, Jong Eun, Kim, Zisun, Han, Sun Wook, Hur, Sung Mo, Kim, Sung Young, Lim, Cheol Wan, Lee, Min Hyuk, Lee, Jihyoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729121/
https://www.ncbi.nlm.nih.gov/pubmed/29250506
http://dx.doi.org/10.4174/astr.2017.93.6.287
_version_ 1783286134038593536
author Jung, Hong Kyu
Park, Suyeon
Kim, Nam Won
Lee, Jong Eun
Kim, Zisun
Han, Sun Wook
Hur, Sung Mo
Kim, Sung Young
Lim, Cheol Wan
Lee, Min Hyuk
Lee, Jihyoun
author_facet Jung, Hong Kyu
Park, Suyeon
Kim, Nam Won
Lee, Jong Eun
Kim, Zisun
Han, Sun Wook
Hur, Sung Mo
Kim, Sung Young
Lim, Cheol Wan
Lee, Min Hyuk
Lee, Jihyoun
author_sort Jung, Hong Kyu
collection PubMed
description PURPOSE: Breast cancer survivors have slightly increased the risk of second primary cancers. Breast, colon, uterine, and ovarian cancers are common secondary cancers in breast cancer survivors. In this study, we assessed the development of second primary cancers of breast cancer survivors in Korea. METHODS: Medical records of patients with breast cancer in 3 tertiary medical institutions were reviewed retrospectively. We evaluated secondary malignancy diagnosed at least 2 months after the breast cancer diagnosis. Based on the International Classification of Disease-9 codes of malignancies, secondary primary breast cancer records were evaluated with person-year adjustment. The standardized incidence ratio (SIR) was assessed using national cancer incidence. RESULTS: A total of 3,444 treatment records were included from 3 medical centers. The cumulative incidence of overall second primary cancers was 2.8% (n = 93). The SIR was significantly higher in all sites (1.56; 95% confidence interval [CI], 1.26–1.91), endometrial cancer (5.65; 95% CI, 2.06–12.31), biliary tract cancer (3.96; 95% CI, 1.19–8.60), and thyroid cancer (2.29; 95% CI, 1.67–3.08). CONCLUSION: The incidence of cancer was higher in breast cancer survivors compared to general population. Surveillance of secondary cancer in this group should be recommended individually considering the benefit related to the prognosis of primary breast cancer.
format Online
Article
Text
id pubmed-5729121
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Surgical Society
record_format MEDLINE/PubMed
spelling pubmed-57291212017-12-15 Development of second primary cancer in Korean breast cancer survivors Jung, Hong Kyu Park, Suyeon Kim, Nam Won Lee, Jong Eun Kim, Zisun Han, Sun Wook Hur, Sung Mo Kim, Sung Young Lim, Cheol Wan Lee, Min Hyuk Lee, Jihyoun Ann Surg Treat Res Original Article PURPOSE: Breast cancer survivors have slightly increased the risk of second primary cancers. Breast, colon, uterine, and ovarian cancers are common secondary cancers in breast cancer survivors. In this study, we assessed the development of second primary cancers of breast cancer survivors in Korea. METHODS: Medical records of patients with breast cancer in 3 tertiary medical institutions were reviewed retrospectively. We evaluated secondary malignancy diagnosed at least 2 months after the breast cancer diagnosis. Based on the International Classification of Disease-9 codes of malignancies, secondary primary breast cancer records were evaluated with person-year adjustment. The standardized incidence ratio (SIR) was assessed using national cancer incidence. RESULTS: A total of 3,444 treatment records were included from 3 medical centers. The cumulative incidence of overall second primary cancers was 2.8% (n = 93). The SIR was significantly higher in all sites (1.56; 95% confidence interval [CI], 1.26–1.91), endometrial cancer (5.65; 95% CI, 2.06–12.31), biliary tract cancer (3.96; 95% CI, 1.19–8.60), and thyroid cancer (2.29; 95% CI, 1.67–3.08). CONCLUSION: The incidence of cancer was higher in breast cancer survivors compared to general population. Surveillance of secondary cancer in this group should be recommended individually considering the benefit related to the prognosis of primary breast cancer. The Korean Surgical Society 2017-12 2017-12-01 /pmc/articles/PMC5729121/ /pubmed/29250506 http://dx.doi.org/10.4174/astr.2017.93.6.287 Text en Copyright © 2017, the Korean Surgical Society http://creativecommons.org/licenses/by-nc/4.0/ Annals of Surgical Treatment and Research is an Open Access Journal. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jung, Hong Kyu
Park, Suyeon
Kim, Nam Won
Lee, Jong Eun
Kim, Zisun
Han, Sun Wook
Hur, Sung Mo
Kim, Sung Young
Lim, Cheol Wan
Lee, Min Hyuk
Lee, Jihyoun
Development of second primary cancer in Korean breast cancer survivors
title Development of second primary cancer in Korean breast cancer survivors
title_full Development of second primary cancer in Korean breast cancer survivors
title_fullStr Development of second primary cancer in Korean breast cancer survivors
title_full_unstemmed Development of second primary cancer in Korean breast cancer survivors
title_short Development of second primary cancer in Korean breast cancer survivors
title_sort development of second primary cancer in korean breast cancer survivors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729121/
https://www.ncbi.nlm.nih.gov/pubmed/29250506
http://dx.doi.org/10.4174/astr.2017.93.6.287
work_keys_str_mv AT junghongkyu developmentofsecondprimarycancerinkoreanbreastcancersurvivors
AT parksuyeon developmentofsecondprimarycancerinkoreanbreastcancersurvivors
AT kimnamwon developmentofsecondprimarycancerinkoreanbreastcancersurvivors
AT leejongeun developmentofsecondprimarycancerinkoreanbreastcancersurvivors
AT kimzisun developmentofsecondprimarycancerinkoreanbreastcancersurvivors
AT hansunwook developmentofsecondprimarycancerinkoreanbreastcancersurvivors
AT hursungmo developmentofsecondprimarycancerinkoreanbreastcancersurvivors
AT kimsungyoung developmentofsecondprimarycancerinkoreanbreastcancersurvivors
AT limcheolwan developmentofsecondprimarycancerinkoreanbreastcancersurvivors
AT leeminhyuk developmentofsecondprimarycancerinkoreanbreastcancersurvivors
AT leejihyoun developmentofsecondprimarycancerinkoreanbreastcancersurvivors